Twitter | Search | |
Search Refresh
6D Apr 14
Biotechnologický startup vytváří geneticky upravenou ‚superkrev' pro boj s rakovinou a autoimunitními chorobami
Reply Retweet Like
1stOncology Mar 5
Reply Retweet Like
Keith Croes 📰 Mar 2
Reply Retweet Like
Unifi Biotechnologies Mar 1
, a developing red blood cell () therapies is developing replacement meds for rare conditions in which the body doesn't make an enzyme, as well as therapies that aim to re-engineer the body's system.
Reply Retweet Like
Goodwin Jun 23
Goodwin advised on its $120 million :
Reply Retweet Like
Plexus Ventures Jun 22
Reply Retweet Like
IrisDorbian 9 Dec 15
PE HUB | Flagship Ventures provides $25 mln to Rubius Therapeutics:
Reply Retweet Like